Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eduardo Albers Acosta
Observed names:
E. Albers Acosta,
EM Albers Acosta,
Eduardo Albers,
Eduardo Albers-Acosta,
Eduardo Mariano Albers Acosta
Institutions:
University Hospital of Basel,
Hospital Universitario de La Princesa,
Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa,
Universidad Autónoma de Madrid
Observed institutions:
University Hospital of Basel,
Hospital Universitario de La Princesa,
Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa,
Universidad Autónoma de Madrid
ORCID:
0000-0002-0091-6209
Observed ORCID:
0000-0002-0091-6209
OpenAlex ID:
A5079890308
Immunome profiling in prostate cancer: a guide for clinicians
2024
·
Luis San-Jose Manso
, Arantzazu Alfranca
, et al.
·
Frontiers in Immunology
·
11
PDF
Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers
2025
·
Cristina Quicios Dorado
, Clara Velasco Balanza
, et al.
·
Cancers
·
10
PDF
Beyond Visualization: Advanced Imaging, Theragnostics and Biomarker Integration in Urothelial Bladder Cancer
2025
·
Eduardo Albers Acosta
, Lira Pelari Mici
, et al.
·
Cancers
·
9
PDF
A Comprehensive Analysis of Immune Response in Patients with Non-Muscle-Invasive Bladder Cancer
2023
·
Guillermo Celada Luis
, Eduardo Albers Acosta
, et al.
·
Cancers
·
8
PDF
Sample preparation of serum to allow capillary electrophoresis analysis of prostate specific antigen isoforms
2016
·
Noemi Farina-Gomez
, Silvia Barrabes
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
6
Defining statistical cure in patients with T1 high‐grade non‐muscle‐invasive bladder carcinoma treated with BCG immunotherapy
2025
·
José Daniel Subiela
, Irene de la Parra
, et al.
·
British Journal of Urology
·
3
Perioperative Management of Upper Tract Urothelial Carcinoma: Current Evidence and Future Directions
2026
·
Eduardo Albers Acosta
, Jose Daniel Subiela
, et al.
·
Urologia Internationalis
·
1
PDF
Immunoprofiling: A prospective multi-cohort study to characterize circulating immune response in advanced prostate cancer.
2025
·
Paloma Galera
, Patricia Toquero
, et al.
·
Journal of Clinical Oncology
·
1
PDF
El impacto del enfoque multidisciplinar en la elección del tratamiento y los resultados del carcinoma urotelial: una revisión sistemática
2025
·
E. Albers Acosta
, L. Pelari-Mici
, et al.
·
Actas Urológicas Españolas
·
1
Bleeding due to ectopic varices in a urinary diversion: A multidisciplinary diagnostic and therapeutic challenge
2015
·
Eduardo Mariano Albers Acosta
, Alfonsi Friera Reyes
, et al.
·
Canadian Urological Association Journal
·
1
PDF
Patología testicular benigna: hidrocele, criptorquidia y varicocele
2015
·
R. Brime Menéndez
, M.A. Acosta Reveles
, et al.
·
Medicine - Programa de Formación Médica Continuada Acreditado
·
1
Peri-radiotherapy immune remodeling in high-risk localized prostate cancer: A prospective paired immunophenotyping study
2026
·
L. Pelari Mici
, N. Romero Laorden
, et al.
·
European Urology Open Science
PDF
Perioperative enfortumab vedotin–pembrolizumab, gemcitabine-cisplatin–durvalumab, and dose-dense MVAC in cisplatin-eligible muscle-invasive bladder cancer: A benefit-risk Bayesian network meta-analysis
2026
·
José Daniel Subiela
, Daniel A. González-Padilla
, et al.
·
Urologic Oncology Seminars and Original Investigations
Clinical and microbiological characteristics and outcomes of complicated urinary tract infections managed in a hospital-at-home programme: a prospective observational cohort study
2026
·
Lira Pelari-Mici
, Elena Arranz Canales
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
PDF
Captación bilateral testicular en PET-TC con 18F-DCFPyL en pacientes con cáncer de próstata: reporte de dos casos
2026
·
L. Pelari Mici
, R. Jover Díaz
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular
Impact of re‐transurethral resection of bladder staging on risk stratification of high‐grade T1 non‐muscle‐invasive bladder cancer across European Association of Urology 2021 risk groups
2026
·
Ana Fernández‐Mardomingo
, Jose Daniel Subiela
, et al.
·
British Journal of Urology
CCL21 as a treatment-linked prognostic biomarker in metastatic castration-resistant prostate cancer.
2026
·
Paloma Galera
, Arantza Alfranca
, et al.
·
Journal of Clinical Oncology
PDF
Bilateral testicular uptake in 18F-DCFPyL PET-CT in prostate cancer patients: report of two cases
2026
·
Lira Pelari-Mici
, Raquel Jover Díaz
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Ureteral and Vascular Events During Robotic Post-Chemotherapy Retroperitoneal Lymph Node Dissection: Technical Insights and Management Considerations
2026
·
Manuel Saavedra Centeno
, Eduardo Albers Acosta
, et al.
·
Complications
PDF
A0873 – Can Bacillus Calmette-Guérin cure patients with high-grade T1 non-muscle-invasive bladder carcinoma? A multicenter analysis of cure fraction and conditional survival of oncological outcomes
2025
·
P. Del Olmo Duran
, J.D. Subiela Henríquez
, et al.
·
European Urology
The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review
2025
·
E. Albers Acosta
, L. Pelari-Mici
, et al.
·
Actas Urológicas Españolas (English Edition)
P285 Does the presence of detrusor muscle in the initial transurethral resection affect the efficacy of immediate second transurethral resection in improving recurrence and progression in T1 high-grade non-muscle invasive bladder carcinoma?
2024
·
J.D. Subiela Henriquez
, O. Buisan
, et al.
·
European Urology Open Science
Tratamiento de la litiasis con laparoscopia. Técnicas combinadas
2017
·
Inmaculada Fernández González
, Ricardo Brime Menéndez
, et al.
·
Archivos Españoles de Urología
Show more works
View as search
Works count:
23
Citation count:
52
H-index:
5
I10-index:
2
Year
Topic
Type